Kevin Winthrop

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin	Chemically-Induced Disorders, Drug-Induced Ototoxicity, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, Neurologic Manifestations, Ototoxicity, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, injury, nervous system disorder, otorhinolaryngologic disease, radiation injury	Recruiting	Phase 2	2026-10-01		NCT05730283
Epetraborole in Patients With Mycobacterium Abscessus Lung Disease	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Mycobacterium Infections, Nontuberculous, Mycobacterium abscessus Infection, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease	Recruiting	Phase 2	2026-05-06		NCT07301320

Clinical trials